Genomics

Farhad Danesh examines how mitochondrial reactive oxygen species, altered metabolism and structural remodelling convert hyperglycaemia into progressive kidney injury. The seminar connects mitochondrial dynamics with diabetic microvascular damage, non-coding RNA regulation and experimental models that establish causal links to disease progression. Genome-wide CRISPR screens and spatial metabolomics reveal cellular gene-regulatory and metabolic changes. Integrating these approaches with molecular genetics, genomics and epigenomics, the work seeks therapeutic targets to prevent diabetic kidney disease progressing to kidney failure. Hybrid: New Research Building Auditorium, Georgetown University Medical Center, Washington, DC, and Zoom. Thursday 24 September 2026, 16:00–17:00 EDT (America/New_York; UTC−4). Use the public event registration form to arrange attendance, or follow its Zoom link for remote participation. Organized by Georgetown’s Distinguished Scientist Seminar Series. Danesh is Professor of Medicine and Chief of Nephrology at MD Anderson.

MIT Biology Colloquium Series talk by Peter Koo (Cold Spring Harbor Laboratory), hosted by Yunha Hwang, on using AI to learn the gene regulatory code.

Peter Meikle, Bernie Pope and Tingting Wang present the Australian Cardiovascular disease Data Commons (ACDC). Some heart attacks occur without established risk factors, and repeat events remain common despite optimal treatment. ACDC addresses this gap by securely pooling multi-omics, imaging and longitudinal outcomes from approximately 400,000 people in 18 Australian cohorts. The webinar explains cloud infrastructure, data harmonisation and federated standards based on Gen3; how integrated genomic, multi-omics and imaging cohorts support new risk markers and polygenic risk-score testing; and how the platform can move diagnostic research towards clinical practice. Meikle and Wang are at the Baker Heart and Diabetes Institute; Pope is at Australian BioCommons. Online via Zoom. Wednesday 30 September 2026, 12:00–13:00 AEST (Australia/Melbourne; UTC+10). Free, with advance registration through the official event page. Intended for life scientists, bioinformaticians, cardiovascular clinicians, data custodians and medical data scientists. Parts may be recorded; the Australian BioCommons Code of Conduct applies. Organized by Australian BioCommons.

Tom Nowakowski explains lineage barcoding and single-cell sequencing approaches for reconstructing neural stem-cell family trees and early wiring programs in developing mouse and human brains.

Jiaqi Zhang examines how computational models can learn the effects of genetic interventions from single-cell experiments. Such experiments reveal causal relationships, but their high-dimensional measurements are costly to collect and difficult to interpret. The seminar connects identifiable causal representations with a predictive method for previously unseen perturbations. The approach incorporates prior biological knowledge and changes in data distributions to estimate responses at individual-cell resolution. It also uses predictions to guide subsequent experiments. An application identifies and experimentally validates previously unknown T-cell regulators with potential relevance to cancer immunotherapy. The recording follows the original July seminar; the series lists Zhang at MIT, while the recording biography describes her incoming Columbia appointment.

A postdoctoral fellowship at Unicamp’s Institute of Biology integrates genomic and multiomic data to improve genome assembly and functional annotation in bees. Work includes sample preparation, Hi-C, RNA-seq, TSS-seq and ATAC-seq, integration with long-read data, reproducible analysis pipelines and student training. The position is in Campinas, Brazil, with a planned January 2027 start. Applications close on 25 September 2026; the official selection notice explains the required documents and submission method.

Three-year postdoctoral fellowships combining experimental and computational research through collaborative projects between EMBL-EBI and the Wellcome Sanger Institute on the Wellcome Genome Campus, to start as soon as possible after award.

The Dorrity group at EMBL Heidelberg seeks a Laboratory Officer to investigate gene regulation and cellular identity with single-cell genomics. Work includes mammalian cell culture and engineering, adapting low-input RNA-sequencing protocols, sequencing-library preparation, CRISPR experiments and laboratory training and management. The three-year, full-time position is based on campus. The advert gives a closing date of 30 September 2026 at 23:59 CET.

Lead an approximately 15-person team responsible for plant, invertebrate and genetic-variation resources in Ensembl and the European Variation Archive. This faculty position combines scientific strategy, genomic data services, staff and budget management, fundraising and community partnerships. The team supports crop genomics and variation research across species. The appointment is for five years, renewable up to nine, with hybrid working in Hinxton.

Peter Meikle, Bernie Pope and Tingting Wang present the Australian Cardiovascular disease Data Commons (ACDC). Some heart attacks occur without established risk factors, and repeat events remain common despite optimal treatment. ACDC addresses this gap by securely pooling multi-omics, imaging and longitudinal outcomes from approximately 400,000 people in 18 Australian cohorts. The webinar explains cloud infrastructure, data harmonisation and federated standards based on Gen3; how integrated genomic, multi-omics and imaging cohorts support new risk markers and polygenic risk-score testing; and how the platform can move diagnostic research towards clinical practice. Meikle and Wang are at the Baker Heart and Diabetes Institute; Pope is at Australian BioCommons. Online via Zoom. Wednesday 30 September 2026, 12:00–13:00 AEST (Australia/Melbourne; UTC+10). Free, with advance registration through the official event page. Intended for life scientists, bioinformaticians, cardiovascular clinicians, data custodians and medical data scientists. Parts may be recorded; the Australian BioCommons Code of Conduct applies. Organized by Australian BioCommons.

Junjie Guo investigates how an intronic nucleotide-repeat expansion in C9orf72 causes familial and some sporadic cases of amyotrophic lateral sclerosis and frontotemporal dementia. The talk presents progress in understanding how the expansion changes gene expression, alongside functional-genomics approaches that identify potential therapeutic targets controlling expression of the pathogenic mutation. It also considers which mechanisms and modifiers extend to other disease-causing repeat expansions. Guo is Associate Professor of Neuroscience at Yale School of Medicine; the seminar is hosted by J. Wren Kim. Online via CUNY ASRC Zoom. Thursday 8 October 2026, 12:00–13:00 EDT (America/New_York; UTC−4). Follow the Zoom link on the official seminar page; meeting details are also supplied in its abstract PDF. Organized by the Advanced Science Research Center at the CUNY Graduate Center, Neuroscience Initiative. This listing advertises remote attendance.

Farhad Danesh examines how mitochondrial reactive oxygen species, altered metabolism and structural remodelling convert hyperglycaemia into progressive kidney injury. The seminar connects mitochondrial dynamics with diabetic microvascular damage, non-coding RNA regulation and experimental models that establish causal links to disease progression. Genome-wide CRISPR screens and spatial metabolomics reveal cellular gene-regulatory and metabolic changes. Integrating these approaches with molecular genetics, genomics and epigenomics, the work seeks therapeutic targets to prevent diabetic kidney disease progressing to kidney failure. Hybrid: New Research Building Auditorium, Georgetown University Medical Center, Washington, DC, and Zoom. Thursday 24 September 2026, 16:00–17:00 EDT (America/New_York; UTC−4). Use the public event registration form to arrange attendance, or follow its Zoom link for remote participation. Organized by Georgetown’s Distinguished Scientist Seminar Series. Danesh is Professor of Medicine and Chief of Nephrology at MD Anderson.

Jiaqi Zhang examines how computational models can learn the effects of genetic interventions from single-cell experiments. Such experiments reveal causal relationships, but their high-dimensional measurements are costly to collect and difficult to interpret. The seminar connects identifiable causal representations with a predictive method for previously unseen perturbations. The approach incorporates prior biological knowledge and changes in data distributions to estimate responses at individual-cell resolution. It also uses predictions to guide subsequent experiments. An application identifies and experimentally validates previously unknown T-cell regulators with potential relevance to cancer immunotherapy. The recording follows the original July seminar; the series lists Zhang at MIT, while the recording biography describes her incoming Columbia appointment.